Genetic analysis has led to the successful diagnosis and treatment of a young girl with Progressive Dystonia. The girl, unable to speak or move, is now able to move around, speak, laugh, and play.
With the demand for direct-to-consumer genetic tests on the rise, a new analysis has questioned how reliable the results really are.
Researchers have taken a step closer to the goal of precision medicine for treating glaucoma and other neurodegenerative vision diseases.
Head of the FDA, Scott Gottlieb has suggested some ways in which pharma giants could rethink their business models, to help unproductive drugmakers.
A team of researchers is finding different ways of using existing drugs to treat the rarest of diseases, saving huge research costs.
Chinese pharmaceutical companies are proving their place in the US generic drugs market, with a rising number of approvals for copycat medicines almost doubling in the past year.
UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population.
The full benefit of using AI-tools to make predictions and take alternative actions can’t be realised without careful consideration of the accompanying ethical pitfalls, say researchers.
FDNA has announced a Genomics Collaborative, with the aim of developing new precision medicine approaches that builds on partnerships already underway in the research community.
Google has announced a partnership with WuXi NextCODE, with the aim of enhancing its comprehensive genomics capabilities.
Researchers have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukaemia would relapse following treatment.